Our conclusion that EARS2 expression might be a risk factor for pancreatic cancer in breast cancer patients with PALB2 mutations is based on mRNA expression since there were only 2 pancreatic cancers and no breast cancers with a PALB2 mutation. Here, EARS2 is linked to familial pancreatic carcinoma.